- Browse by Author
Browsing by Author "Bifarin, Olatomiwa O."
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Machine Learning Reveals Lipidome Remodeling Dynamics in a Mouse Model of Ovarian Cancer(Cold Spring Harbor Laboratory, 2023-01-04) Bifarin, Olatomiwa O.; Sah, Samyukta; Gaul, David A.; Moore, Samuel G.; Chen, Ruihong; Palaniappan, Murugesan; Kim, Jaeyeon; Matzuk, Martin M.; Fernández, Facundo M.; Biochemistry and Molecular Biology, School of MedicineOvarian cancer (OC) is one of the deadliest cancers affecting the female reproductive system. It may present little or no symptoms at the early stages, and typically unspecific symptoms at later stages. High-grade serous ovarian cancer (HGSC) is the subtype responsible for most ovarian cancer deaths. However, very little is known about the metabolic course of this disease, particularly in its early stages. In this longitudinal study, we examined the temporal course of serum lipidome changes using a robust HGSC mouse model and machine learning data analysis. Early progression of HGSC was marked by increased levels of phosphatidylcholines and phosphatidylethanolamines. In contrast, later stages featured more diverse lipids alterations, including fatty acids and their derivatives, triglycerides, ceramides, hexosylceramides, sphingomyelins, lysophosphatidylcholines, and phosphatidylinositols. These alterations underscored unique perturbations in cell membrane stability, proliferation, and survival during cancer development and progression, offering potential targets for early detection and prognosis of human ovarian cancer.Item Serum Lipidome Profiling Reveals a Distinct Signature of Ovarian Cancer in Korean Women(American Association for Cancer Research, 2024) Sah, Samyukta; Bifarin, Olatomiwa O.; Moore, Samuel G.; Gaul, David A.; Chung, Hyewon; Kwon, Sun Young; Cho, Hanbyoul; Cho, Chi-Heum; Kim, Jae-Hoon; Kim, Jaeyeon; Fernández, Facundo M.; Biochemistry and Molecular Biology, School of MedicineBackground: Distinguishing ovarian cancer from other gynecological malignancies is crucial for patient survival yet hindered by non-specific symptoms and limited understanding of ovarian cancer pathogenesis. Accumulating evidence suggests a link between ovarian cancer and deregulated lipid metabolism. Most studies have small sample sizes, especially for early-stage cases, and lack racial/ethnic diversity, necessitating more inclusive research for improved ovarian cancer diagnosis and prevention. Methods: Here, we profiled the serum lipidome of 208 ovarian cancer, including 93 early-stage patients with ovarian cancer and 117 nonovarian cancer (other gynecological malignancies) patients of Korean descent. Serum samples were analyzed with a high-coverage liquid chromatography high-resolution mass spectrometry platform, and lipidome alterations were investigated via statistical and machine learning (ML) approaches. Results: We found that lipidome alterations unique to ovarian cancer were present in Korean women as early as when the cancer is localized, and those changes increase in magnitude as the diseases progresses. Analysis of relative lipid abundances revealed specific patterns for various lipid classes, with most classes showing decreased abundance in ovarian cancer in comparison with other gynecological diseases. ML methods selected a panel of 17 lipids that discriminated ovarian cancer from nonovarian cancer cases with an AUC value of 0.85 for an independent test set. Conclusions: This study provides a systemic analysis of lipidome alterations in human ovarian cancer, specifically in Korean women.